Valbona Mirakaj

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Coronavirus Disease

Lipopolysaccharide Induced

Top Venues

Hepatology (Baltimore, Md.)

The Journal of experimental medicine

ImmunoTargets and therapy

Eberhard Karls Universität Tübingen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Eberhard Karls Universität Tübingen

Germany

Head of Division :: Anesthesiology and Intensive Care Medicine

Publications

Romain Barnault, Claire Verzeroli, Carole Fournier, Maud Michelet, Anna-Rita Redavid, Ievgeniia Chicherova, Marie-Laure Plissonnier, Annie Adrait, Olga Khomich, Fleur Chapus, Mathieu Richaud, Maëva Hervieu, Veronika Reiterer, Federica Grazia Centonze, Julie Lucifora, Birke Bartosch, Michel Rivoire, Hesso Farhan, Yohann Cout, Valbona Mirakaj, Thomas Decaens, Patrick Mehlen, Benjamin Gibert, Fabien Zoulim, Romain Parent
Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translation. Hepatology (Baltimore, Md.) 76 (5) (2022)
Helena C Brown, Sarah Beck, Stefano Navarro, Ying Di, Eva M Soriano Jerez, Jana Kaczmarzyk, Steven G Thomas, Valbona Mirakaj, Stephen P Watson, Bernhard Nieswandt, David Stegner
Antibody-mediated depletion of human CLEC-2 in a novel humanised mouse model. Blood advances (2022)
Valbona Mirakaj
Immune cells-A curse and a blessing! The Journal of experimental medicine 218 (6) (2021)
Jan Zlamal, Karina Althaus, Hisham Jaffal, Helene A Haeberle, Lisann Pelzl, Anurag Singh, Andreas Witzemann, Karoline Weich, Michael Bitzer, Nisar Malek, Siri Goepel, Hans Bösmüller, Meinrad Gawaz, Valbona Mirakaj, Peter Rosenberger, Tamam Bakchoul
Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19. Blood advances (2021)
Verena Gudernatsch, Sylwia Anna Stefańczyk, Valbona Mirakaj
Novel Resolution Mediators of Severe Systemic Inflammation. ImmunoTargets and therapy 9 (2020)